Regulation of interleukin-1 in acute brain injury.

[1]  S. Akira,et al.  Addendum: Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1β production , 2013, Nature Immunology.

[2]  G. López-Castejón,et al.  Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules , 2011, Cellular and Molecular Life Sciences.

[3]  A. Algra,et al.  Excess Mortality and Cardiovascular Events in Patients Surviving Subarachnoid Hemorrhage: A Nationwide Study in Sweden , 2011, Stroke.

[4]  M. Lamkanfi.  Emerging inflammasome effector mechanisms , 2011, Nature Reviews Immunology.

[5]  K. Herholz,et al.  Brain inflammation is induced by co-morbidities and risk factors for stroke , 2011, Brain, Behavior, and Immunity.

[6]  C. Serhan,et al.  Specialized pro-resolving lipid mediators in the inflammatory response: An update. , 2010, Biochimica et biophysica acta.

[7]  Grace Y Chen,et al.  Sterile inflammation: sensing and reacting to damage , 2010, Nature Reviews Immunology.

[8]  Denis Gris,et al.  The Inflammasome Sensor, NLRP3, Regulates CNS Inflammation and Demyelination via Caspase-1 and Interleukin-18 , 2010, The Journal of Neuroscience.

[9]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[10]  N. Rothwell,et al.  Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  M. Schwartz,et al.  Systemic inflammatory cells fight off neurodegenerative disease , 2010, Nature Reviews Neurology.

[12]  B. McColl,et al.  Platelet interleukin-1alpha drives cerebrovascular inflammation. , 2010, Blood.

[13]  M. Shipston,et al.  A Role for Potassium Permeability in the Recognition, Clearance, and Anti-inflammatory Effects of Apoptotic Cells , 2010, Molecular Neurobiology.

[14]  K. Rock,et al.  Identification of the Cellular Sensor That Stimulates the Inflammatory Response to Sterile Cell Death , 2010, The Journal of Immunology.

[15]  Fernando Ontiveros,et al.  The sterile inflammatory response. , 2010, Annual review of immunology.

[16]  C. Dinarello.  Anti-inflammatory Agents: Present and Future , 2010, Cell.

[17]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[18]  V. Hornung,et al.  Critical functions of priming and lysosomal damage for NLRP3 activation , 2010, European journal of immunology.

[19]  F. Martinon.  Signaling by ROS drives inflammasome activation , 2010, European journal of immunology.

[20]  F. Sutterwala,et al.  Sterile inflammatory responses mediated by the NLRP3 inflammasome , 2010, European journal of immunology.

[21]  Jiping Tang,et al.  Ac-YVAD-CMK Decreases Blood–Brain Barrier Degradation by Inhibiting Caspase-1 Activation of Interleukin-1β in Intracerebral Hemorrhage Mouse Model , 2010, Translational Stroke Research.

[22]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[23]  Y. Carmi,et al.  Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation , 2010, Proceedings of the National Academy of Sciences.

[24]  F. Sutterwala,et al.  Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome , 2009, Proceedings of the National Academy of Sciences.

[25]  John H. Zhang,et al.  Caspase-1 Inhibitor Prevents Neurogenic Pulmonary Edema After Subarachnoid Hemorrhage in Mice , 2009, Stroke.

[26]  B. McColl,et al.  Nuclear retention of IL‐1α by necrotic cells: A mechanism to dampen sterile inflammation , 2009, European journal of immunology.

[27]  V. Dixit,et al.  Glyburide inhibits the Cryopyrin/Nalp3 inflammasome , 2009, The Journal of cell biology.

[28]  R. Dana,et al.  Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. , 2009, Investigative ophthalmology & visual science.

[29]  F. Re,et al.  Cutting Edge: Necrosis Activates the NLRP3 Inflammasome1 , 2009, The Journal of Immunology.

[30]  D. Brough,et al.  Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy , 2009, British journal of pharmacology.

[31]  D. Seyfried,et al.  A novel calpastatin-based inhibitor improves postischemic neurological recovery. , 2009, Biochemical and biophysical research communications.

[32]  Steffen Jung,et al.  Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in Mice , 2009, PLoS medicine.

[33]  C. Eder.  Mechanisms of interleukin-1beta release. , 2009, Immunobiology.

[34]  A. Surprenant,et al.  Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1β release through pyrophosphates , 2009, The EMBO journal.

[35]  J. Lehár,et al.  Synergistic drug combinations improve therapeutic selectivity , 2009, Nature Biotechnology.

[36]  Marc Fisher,et al.  Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations , 2009, Stroke.

[37]  H. Bramlett,et al.  Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  Y. Yin,et al.  Inflammasomes are Differentially Expressed in Cardiovascular and other Tissues , 2009, International journal of immunopathology and pharmacology.

[39]  J. P. de Rivero Vaccari,et al.  Inhibition of the Inflammasome Complex Reduces the Inflammatory Response after Thromboembolic Stroke in Mice , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  Catherine Rabouille,et al.  Mechanisms of regulated unconventional protein secretion , 2009, Nature Reviews Molecular Cell Biology.

[41]  F. Sutterwala,et al.  Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. , 2009, The Journal of clinical investigation.

[42]  J. Simard,et al.  Protective Effect of Delayed Treatment With Low-Dose Glibenclamide in Three Models of Ischemic Stroke , 2009, Stroke.

[43]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[44]  K. Rock,et al.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.

[45]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[46]  C. Haslett,et al.  Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation. , 2008, Trends in pharmacological sciences.

[47]  S. Hopkins,et al.  Acute ischaemic stroke and infection: recent and emerging concepts , 2008, The Lancet Neurology.

[48]  J. P. de Rivero Vaccari,et al.  A Molecular Platform in Neurons Regulates Inflammation after Spinal Cord Injury , 2008, The Journal of Neuroscience.

[49]  N. Rothwell,et al.  Interleukin-1 Receptor Antagonist Penetrates Human Brain at Experimentally Therapeutic Concentrations , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[50]  N. Rothwell,et al.  The Dynamics and Mechanisms of Interleukin-1α and β Nuclear Import , 2008, Traffic.

[51]  C. Andry,et al.  Resolvin E1 Regulates Inflammation at the Cellular and Tissue Level and Restores Tissue Homeostasis In Vivo1 , 2007, The Journal of Immunology.

[52]  N. Rothwell,et al.  A selective, non-peptide caspase-1 inhibitor, VRT-018858, markedly reduces brain damage induced by transient ischemia in the rat , 2007, Neuropharmacology.

[53]  F. Martinon,et al.  Inflammasome Components NALP 1 and 3 Show Distinct but Separate Expression Profiles in Human Tissues Suggesting a Site-specific Role in the Inflammatory Response , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[54]  T. Gasser,et al.  ANALYSIS OF INTRATHECAL INTERLEUKIN‐6 AS A POTENTIAL PREDICTIVE FACTOR FOR VASOSPASM IN SUBARACHNOID HEMORRHAGE , 2007, Neurosurgery.

[55]  N. Rothwell,et al.  Caspase-1-dependent processing of pro-interleukin-1β is cytosolic and precedes cell death , 2007, Journal of Cell Science.

[56]  G. Hankey.  Potential New Risk Factors for Ischemic Stroke: What Is Their Potential? , 2006, Stroke.

[57]  G. Donnan,et al.  1,026 Experimental treatments in acute stroke , 2006, Annals of neurology.

[58]  M. T. Hasan,et al.  IKK mediates ischemia-induced neuronal death , 2005, Nature Medicine.

[59]  N. Rothwell,et al.  A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[60]  N. Rothwell,et al.  Interleukin-1 and neuronal injury , 2005, Nature Reviews Immunology.

[61]  J. Braudeau,et al.  Activation of Proinflammatory Caspases by Cathepsin B in Focal Cerebral Ischemia , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[62]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[63]  R. Soldi,et al.  S100A13 mediates the copper-dependent stress-induced release of IL-1α from both human U937 and murine NIH 3T3 cells , 2003, Journal of Cell Science.

[64]  John Savill,et al.  A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.

[65]  S. Kassis,et al.  Inhibition of p38 mitogen‐activated protein kinase provides neuroprotection in cerebral focal ischemia , 2001, Medicinal research reviews.

[66]  Y. Itoyama,et al.  Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. , 1995, Stroke.

[67]  J. Tschopp,et al.  The Inflammasomes , 2010, Cell.